Related Experiment Video
Updated: Jul 21, 2026
07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
Genetic alterations and biological pathways in human bladder cancer pathogenesis
1University of Wisconsin, Comprehensive Cancer Center and Medical School, Departments of Human Oncology, Surgery and Biostatistics, 600 Highland Avenue 53792, Madison, WI, USA
Urologic Oncology
|September 6, 2000
Summary
Genetic alterations in bladder cancer vary by tumor type. Superficial papillary TCCs often show chromosome 9q loss early, while CIS and SCC have TP53 and CDKN2/p16 alterations, influencing cancer progression.
Area of Science:
- Urology
- Oncology
- Cancer Genetics
Background:
- Human bladder cancers exhibit significant heterogeneity.
- Different subtypes, including papillary transitional cell carcinoma (TCC), carcinoma in situ (CIS), and squamous cell carcinoma (SCC), display distinct clinical behaviors and progression patterns.
Purpose of the Study:
- To investigate the genetic alterations associated with different subtypes of human bladder cancer.
- To correlate specific genetic changes with the initiation and progression of various bladder cancer manifestations.
Main Methods:
- Analysis of genetic alterations, including chromosomal losses and gene mutations (TP53, CDKN2/16), in different bladder cancer subtypes.
- Comparison of genetic profiles between superficial papillary TCC, CIS, and SCC.
Main Results:
- Superficial papillary TCCs frequently exhibit early 9q chromosomal loss (approx. 67%), with rare TP53 or CDKN2/16 mutations.
- Bladder CIS and SCC show lower rates of 9q loss but high frequencies of TP53 alterations (approx. 65% for CIS) and CDKN2/p16 alterations (approx. 67% for SCC), respectively.
- These genetic alterations are linked to genome instability and cell growth regulation, correlating with aggressive phenotypes.
Conclusions:
- The predominant genetic alteration may serve as the initiating event in bladder cancer pathogenesis.
- Specific genetic alterations appear to determine the biological potential and clinical course of different bladder cancer subtypes.
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...